Search results
Is It Worth Investing in CVS Health (CVS) Based on Wall Street's Bullish Views?
Zacks via Yahoo Finance UK· 4 days agoBased on the average brokerage recommendation (ABR), CVS Health (CVS) should be added to one's...
Investors Heavily Search CVS Health Corporation (CVS): Here is What You Need to Know
Zacks via Yahoo Finance UK· 4 days agoCVS Health (CVS) has received quite a bit of attention from Zacks.com users lately. Therefore, it is...
US advisers to consider RSV shots as GSK looks to keep market lead
Reuters· 4 days ago, opens new tab to keep its top position in the market. The Centers for Disease Control and...
10 of the most exciting digital health startups of 2024, according to VCs
TechCrunch· 4 days agoIn the post-COVID world, VCs say it’s not as easy to get excited about investing in digital health....
Judge Rules Against MedImpact In $200M Rite Aid Debt Dispute
Benzinga via Yahoo Finance UK· 5 days agoU.S. Bankruptcy Judge Michael Kaplan ruled that MedImpact assumed Elixir’s debts when it acquired...
Flexjobs Ranks 75 Companies For Remote Jobs In The Summer Of 2024
Forbes· 5 days agoAs employees continue to look for remote job opportunities, FlexJobs has recently unveiled its...
Rite Aid defeats MedImpact in $200 million Elixir sale dispute
Reuters· 6 days ago, opens new tab pharmacy benefit unit failed after a judge ruled on Monday that it took on Elixir's...
Rite Aid defeats MedImpact in $200 million Elixir sale dispute
Reuters via Yahoo Finance UK· 6 days agoMedImpact's attempt to recoup about $200 million related to its purchase of Rite Aid's pharmacy...
Rite Aid Wins $200 Million Dispute Over Elixir Sale to MedImpact
Bloomberg via Yahoo Finance UK· 6 days ago(Bloomberg) -- Rite Aid Corp. isn’t responsible for more than $200 million in extra costs tied to...
Rite Aid Wins $200 Million Dispute Over Elixir Sale to MedImpact
Bloomberg· 6 days agoHave a confidential tip for our reporters? Judge Michael Kaplan said during a hearing in New Jersey...